BioXcel Therapeutics, Inc. Payments of Debt Issuance Costs
BioXcel Therapeutics, Inc. (BTAI) reported Payments of Debt Issuance Costs of $180.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-28.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfDebtIssuanceCosts · last filed 2025-03-28
- BioXcel Therapeutics, Inc. payments of debt issuance costs for the quarter ending 2022-12-31 was $0.00.
- BioXcel Therapeutics, Inc. payments of debt issuance costs for the quarter ending 2022-09-30 was $0.00.
- BioXcel Therapeutics, Inc. payments of debt issuance costs for fiscal 2023 was $180.00K, a 93.20% decline from fiscal 2022.
- BioXcel Therapeutics, Inc. payments of debt issuance costs for fiscal 2022 was $2.65M.
| Period end | Payments of Debt Issuance Costs 3 month | Payments of Debt Issuance Costs 6 month | Payments of Debt Issuance Costs 9 month | Payments of Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2023-12-31 | $180.00K 10-K · filed 2025-03-28 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | $0.00 derived: sum of 2 quarters · filed 2024-03-22 | $2.65M 10-K · filed 2024-03-22 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $2.65M 10-Q · filed 2023-11-14 | ||
| 2022-06-30 | $2.65M 10-Q · filed 2023-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |